EWTX - Edgewise Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

EWTX is currently covered by 6 analysts with an average price target of $32.11. This is a potential upside of $19.16 (147.95%) from yesterday's end of day stock price of $12.95.

Edgewise Therapeutics's activity chart (see below) currently has 24 price targets and 45 ratings on display. The stock rating distribution of EWTX is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 57.38% with an average time for these price targets to be met of 322.14 days.

Highest price target for EWTX is $51, Lowest price target is $31, average price target is $45.

Most recent stock forecast was given by LAURA CHICO from WEDBUSH on 21-Apr-2025. First documented stock forecast 19-Apr-2021.

Currently out of the existing stock ratings of EWTX, 27 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$43

$28.74 (201.54%)

$45

3 months 18 days ago
(21-Apr-2025)

6/10 (60%)

$29.7 (223.31%)

297

Buy

$51

$36.74 (257.64%)

$51

4 months 6 days ago
(02-Apr-2025)

0/4 (0%)

$35.48 (228.61%)

Buy

$50

$35.74 (250.63%)

$45

7 months 22 days ago
(17-Dec-2024)

0/2 (0%)

$19.83 (65.73%)

Buy

$50

$35.74 (250.63%)

$33

8 months 12 days ago
(27-Nov-2024)

3/4 (75%)

$17.8 (55.28%)

211

Buy

$31

$16.74 (117.39%)

$30

11 months 27 days ago
(12-Aug-2024)

10/10 (100%)

$13.95 (81.82%)

631

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is EWTX (Edgewise Therapeutics) average time for price targets to be met?

On average it took 322.14 days on average for the stock forecasts to be realized with a an average price target met ratio 57.38

Which analyst has the current highest performing score on EWTX (Edgewise Therapeutics) with a proven track record?

LAURA CHICO

Which analyst has the current lower performing score on EWTX (Edgewise Therapeutics) with a proven track record?

CORY KASIMOV

Which analyst has the most public recommendations on EWTX (Edgewise Therapeutics)?

Laura Chico works at WEDBUSH and has 0 price targets and 0 ratings on EWTX

Which analyst is the currently most bullish on EWTX (Edgewise Therapeutics)?

Yasmeen Rahimi with highest potential upside - $36.74

Which analyst is the currently most reserved on EWTX (Edgewise Therapeutics)?

Madhu Kumar with lowest potential downside - -$9.26

Edgewise Therapeutics in the News

We're Not Very Worried About Edgewise Therapeutics' (NASDAQ:EWTX) Cash Burn Rate

Explore Edgewise Therapeutics’s Fair Values from the Community and select yours Even when a business is losing money, it’s possible for shareholders to make money if they buy a good business at the right price. For example, biotech and mining exploration companies often lose money for years before finding success with a new treatment or...

Edgewise Therapeutics Inc (NASDAQ:EWTX) Q2 2025 Earnings: EPS Beat Sparks 5% Pre-Market Rally

EDGEWISE THERAPEUTICS INC (NASDAQ:EWTX [https://www.chartmill.com/stock/quote/EWTX]) REPORTS Q2 2025 EARNINGS: EPS BEATS ESTIMATES, MARKET RESPONDS POSITIVELY Edgewise Therapeutics Inc, a clinical-stage biopharmaceutical company focused on muscle diseases, reported its second-quarter 2025 financial results, with a narrower-than-expected loss per share and no revenue, in line with analyst expectations. The market reaction has been positive, with shares rising...
Show more

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?